Skip to main content

Table 1 Data used for testing model/matrices

From: Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali

Observed baseline prevalence (%)

Dataset

Data type

Description

Sample size (n)

Overall prevalence

Low intensity

Moderate intensity

High intensity

1

Uganda longitudinal baseline to year 3

Full longitudinal data set

747

43.0

16.6

11.4

15.0

2

Uganda longitudinal baseline to year 3

4a Ugandan districts out of 7

400

46.5

15.5

12.3

18.8

3

Uganda cross-sectional baseline to year 3

Varying sample size per year, full programme data

Baseline: 4,222;

Year 1: 3,973;

Year 2: 4,192;

Year 3: 3,373

45.2

16.0

11.7

17.6

4

Mali longitudinal baseline to year 2

Full longitudinal data set

897

26.5

12.5

7.1

6.9

  1. aThese districts were selected for their wide range of infection intensities and NOT used to the development of matrix C